Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Ovary graft may be alternative to HRT

Gary Finn
Thursday 23 September 1999 00:02 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A BRITISH scientist has successfully completed the world's first ovary graft which could revolutionise the lives of women going through the menopause.

The breakthrough by a joint Anglo-American team, led by Professor Roger Gosden, of Leeds University, was made when the team were able to graft an ovary onto the pelvic wall of a 30-year-old American dancer suffering from early menopause. The ovary was stimulated with hormones and an egg produced in what is being hailed as a medical milestone.

The success of the operation raises the prospect of extending fertility for women into their seventies, new treatment of sterility caused by premature menopause and the possibility of the creation of "ovary banks" where women can store ovaries during cancer treatment to protect their fertility.

One area likely to be affected by the new technique is ageing in menopausal women. The grafts open up the possibility of a safer alternative to hormone replacement therapy.

The details and implications of the procedure are to be unveiled later this week at the American Society for Reproductive medicine in Toronto.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in